Publications 2026
FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab.
Abbadessa G, Chianese U, Russo C, Miele G, Maida E, Esposito G, Romano G, Bile F, Signoriello E, Lus G, Lavorgna L, Nicholas RS, Altucci L, Procaccini C, Matarese G, Benedetti R, Bonavita S.
Neurol Neuroimmunol Neuroinflamm. 2026 Sep;13(5):e200634. doi: 10.1212/NXI.0000000000200634.
IL-6 trans-signalling in cancer metabolism, multidrug resistance and chronic inflammation.
Melisi F, Pasquale LS, Peluso T, Graziano C, Iannarone C, Vicario M, De Iesu MR, Izzo M, Ricciardi R, Bocchetti M, Cossu AM, Matarese G, Scrima M, Caraglia M.
J Biol Chem. 2026 Aug 3:113383. doi: 10.1016/j.jbc.2026.113383.
CCL2: A Pro-Inflammatory Driver and Candidate Diagnostic Biomarker in Colorectal Cancer Patients.
Nardelli C, Nunziato M, Di Maggio F, Gelzo M, Boccia G, Maione F, Peltrini R, Carbone F, Caldora F, Corcione F, De Palma GD, Pilone V, Castaldo G, Matarese G, Salvatore F, Bruzzese D, Sacchetti L.
Int J Mol Sci. 2026 Jul 21;27(14):6470. doi: 10.3390/ijms27146470.
SREBP1c modulates Treg immunobiology through a phospholipid-dependent adenosine pathway.
Bonacina F, Procaccini C, Iaia M, Moretti A, Svecla M, Pedretti S, Bogie JF, Vingiani GB, Moregola A, Genova F, Russo C, De Rosa G, La Rocca C, Mondanelli G, Gargaro M, Mitro N, Matarese G, Norata GD.
J Clin Invest. 2026 Jul 21:e201325. doi: 10.1172/JCI201325.
Thyroid hormone activation drives fibroblast identity and tumor remodeling in cutaneous squamous cell carcinoma.
Di Cicco E, Miro C, Nappi A, Acampora L, Isma J, Sol S, Sagliocchi S, Cicatiello AG, Restolfer F, Ferraro J, Murolo M, Boncimino F, Liu M, Jiménez-Andrade Y, Cerbone V, La Rocca C, Neel VA, Matarese G, Mandinova A, Stornaiuolo M, Dentice M.
Cell Rep. 2026 Jul 8;45(7):117674. doi: 10.1016/j.celrep.2026.117674.
The immunoregulatory role of progesterone during embryo implantation and pregnancy
Colamatteo A, Carbone F, Fusco C, Russo C, Micillo T, Carluccio D, La Rocca C, Zheng W, Longobardi S, Matarese G.
Trends Endocrinol Metab. 2026 Apr 1:S1043-2760(26)00044-5.
Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement.
Musella A, Balletta S, Russo C, Mariani F, Tartacca A, Rosa G, Vito F, Palmerio F, Fresegna D, Bruno A, Dolcetti E, Caioli S, Escarrat V, Buttari F, Carbone F, la Candia A, ...., Salvetti M, Matarese G, Mandolesi G, Procaccini C, Centonze D, Gentile A.
Brain Behav Immun. 2026 Mar 2:106523.
Immunophenotypic skewing of B cells toward IgD⁻CD27⁻IgG⁺ subtype and metabolic attenuation in colorectal cancer.
Martinis E, Tonon S, Valeri V, Colamatteo A, Ricci C, Trevisan C, Capezzali E, Pivetta M, Battista S, Mozzon M, Uzzau A, Matarese G, Cossarizza A, Frossi B, Pucillo C.
Sci Rep. 2026 Feb 28. doi: 10.1038/s41598-026-41446-x.
Effect of dynamics and timing of SARS-CoV-2 vaccination on immune response in people with multiple sclerosis during cladribine treatment
Russo C, Fusco C, Carbone F, Micillo T, La Rocca C, De Rosa G, Di Marino V, Ruggiero K, Garziano F, Perna F, Zannella C, Galdiero M, Franci G, Lanzillo R, Brescia Morra V, Bigi R, Abbadessa G, Bonavita S, Salvetti M, Moccia M, Procaccini C, Matarese G.
Clin Immunol. 2026 Feb 17;284:110683. doi: 10.1016/j.clim.2026.110683.
Multiple sclerosis-associated EBNA2 variants influence the response to peginterferon beta-1a therapy.
Veroni C, Carbone F, Ricci D, Proietti S, Romano S, Buscarinu MC, Rizzo F, Marrone A, Micillo T, Perna F, Garziano F, Guerrera G, Valentino P, Meloni C, Bellucci G, Bertolotto A, Battistini L, Ristori G, Centonze D, Matarese G, Coccia EM, Salvetti M, Severa M, Mechelli R.
J Autoimmun. 2026 Feb 12;159:103533. doi: 10.1016/j.jaut.2026.103533.
